Loading…
Based on limited metadata, this FDA Warning Letter issued to Tarmac Products, Inc. on November 9, 2020, concerns drug manufacturing or distribution violations. Without access to the full letter text or specific subject line, the exact nature of the regulatory concerns cannot be determined from the metadata alone. The warning falls under FDA's drug product oversight, though the specific issuing office is not identified in the available information.